Priorities
Psychedelic Medicine
After a 50 year freeze on psychedelics research, a new psychedelics renaissance is unfolding. As the field rapidly advances, we must continue to ask ethical questions about the safety, accessibility, legality, and public perceptions surrounding these drugs.
The ScattergoodEthics Program examines novel ethical issues in clinical research and treatment with psychedelic drugs such as informed consent, psychedelic professionalism, the inclusion of marginalized populations, and off-label use and marketing.
Latest Work
Perspectives in Biology and Medicine
Read this entryNature Medicine
Read this entryPerspectives in Biology and Medicine
Read this entryAJOB Neuroethics
- Andrew Peterson, PhD
- Emily A. Largent
- Holly Fernandez Lynch, JD, MBE
- Jason Karlawish, MD
- Dominic Sisti, PhD
Cambridge Quarterly of Healthcare Ethics
Read this entry